Alamar Biosciences (ALMR) CFO gets new RSUs and options, restructures Class B options
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Alamar Biosciences Chief Financial Officer Justin J. McAnear reported new equity awards and an option restructuring. He received 37,220 shares of Common Stock as restricted stock units that vest monthly from the grant date, conditioned on his continued service.
He was also granted stock options for 163,358 shares of Common Stock at an exercise price of $17.00 per share, with 25% vesting on April 16, 2027 and the remainder vesting in equal monthly installments thereafter, subject to continued service. In addition, 570,719 stock options with a $4.62 exercise price were reclassified so the underlying security changed from Class B Common Stock to Common Stock in connection with the company’s initial public offering, with no open-market buying or selling reported.
Positive
- None.
Negative
- None.
Insights
CFO received routine equity grants and an option reclassification, with no open‑market trades.
The filing shows equity-based compensation rather than discretionary stock purchases or sales. The CFO received 37,220 restricted stock units and 163,358 stock options at a $17.00 exercise price, both vesting over time based on continued service.
Two larger option positions for 570,719 shares at a $4.62 exercise price were reclassified from Class B Common Stock to Common Stock tied to the initial public offering. This J‑code restructuring changes the share class label but not the economic exposure. Overall, these are standard incentive and structural entries, not strong trading signals.
Insider Trade Summary
4 transactions reported
Mixed
4 txns
Insider
McAnear Justin J.
Role
Chief Financial Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Other | Stock Option (Right to Buy) | 570,719 | $0.00 | -- |
| Other | Stock Option (Right to Buy) | 570,719 | $0.00 | -- |
| Grant/Award | Common Stock | 37,220 | $0.00 | -- |
| Grant/Award | Stock Option (Right to Buy) | 163,358 | $0.00 | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 0 shares (Direct, null);
Common Stock — 37,220 shares (Direct, null)
Footnotes (1)
- Represents the grant of restricted stock units ("RSUs"). The RSUs vest monthly from the date of grant, subject to the reporting person's continuous service as of each such vesting date. Twenty-five percent of the shares subject to the option vest on April 16, 2027, and 1/48th of the shares vest monthly thereafter, subject to the reporting person's continuous service as of each such vesting date. Each share of Class B Common Stock was reclassified into one share of Common Stock immediately prior to the completion of the initial public offering of the Issuer's Common Stock. Twenty-five percent of the shares subject to the option vest on October 13, 2026, and 1/48th of the shares vest monthly thereafter, subject to the reporting person's continuous service through each such vesting date.
Key Figures
RSU grant: 37,220 shares
New stock options: 163,358 shares at $17.00
Reclassified options: 570,719 shares at $4.62
+3 more
6 metrics
RSU grant
37,220 shares
Restricted stock units of Common Stock, vesting monthly from grant date
New stock options
163,358 shares at $17.00
Options on Common Stock, 25% vest on April 16, 2027; remainder monthly
Reclassified options
570,719 shares at $4.62
Options reclassified from Class B Common Stock to Common Stock
Option expiration
October 14, 2035
Expiration date for 570,719-share option grant at $4.62
Option expiration
April 15, 2036
Expiration date for 163,358-share option grant at $17.00
Restructuring shares total
1,141,438 shares
Shares affected by J-code restructuring transactions in the filing
Key Terms
restricted stock units ("RSUs"), Stock Option (Right to Buy), Class B Common Stock, initial public offering, +1 more
5 terms
restricted stock units ("RSUs") financial
"Represents the grant of restricted stock units ("RSUs"). The RSUs vest monthly"
Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.
Stock Option (Right to Buy) financial
"security_title: "Stock Option (Right to Buy)""
Class B Common Stock financial
"Each share of Class B Common Stock was reclassified into one share"
A class B common stock is one of multiple types of a company’s ordinary shares that carries specific rights—often different voting power or dividend priority—compared with other classes. For investors it matters because those differences affect how much influence you have over company decisions, the income you might receive, and how freely the shares trade; think of it like owning a car with different keys: some keys let you start the engine and open the trunk, others only unlock the door.
initial public offering financial
"immediately prior to the completion of the initial public offering"
An initial public offering (IPO) is when a private company first sells its shares to the public and becomes a stock-listed company. It matters because it allows the company to raise money from a wide range of investors, helping it grow, while giving early shareholders a way to sell some of their ownership.
vesting financial
"Twenty-five percent of the shares subject to the option vest on April 16, 2027"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
FAQ
What equity awards did Alamar Biosciences (ALMR) CFO Justin McAnear receive?
Justin McAnear received 37,220 restricted stock units and 163,358 stock options. The options have a $17.00 exercise price and vest over time, aligning his compensation with Alamar Biosciences’ long‑term performance and his continued employment at the company.
How do Justin McAnear’s new RSUs at Alamar Biosciences (ALMR) vest?
The 37,220 restricted stock units vest monthly starting from the grant date. Each monthly tranche requires Justin McAnear’s continuous service with Alamar Biosciences, turning unvested RSUs into fully owned Common Stock over time as service conditions are met.
What are the terms of the new stock options granted to the ALMR CFO?
McAnear’s new options cover 163,358 shares of Common Stock at a $17.00 exercise price. Twenty‑five percent vest on April 16, 2027, and the remaining 75% vest in equal monthly installments thereafter, contingent on his continued service with Alamar Biosciences.
What is the significance of the 570,719 ALMR stock options with a $4.62 exercise price?
The filing shows 570,719 stock options with a $4.62 exercise price whose underlying security changed from Class B Common Stock to Common Stock. This J‑code transaction reflects a reclassification tied to Alamar Biosciences’ IPO, not an open‑market trade.
How do the vesting schedules affect the ALMR CFO’s equity incentives?
Both the RSUs and stock options vest over time, requiring ongoing service. Monthly vesting and initial 25% cliffs for options create long‑term retention incentives, encouraging the CFO to remain at Alamar Biosciences and focus on sustained company performance.